| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases
|
Schultze, Anna
|
|
|
42 |
12 |
p. 3039-3048
|
artikel
|
| 2 |
A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults
|
Cummings, J.F.
|
|
|
42 |
12 |
p. 3066-3074
|
artikel
|
| 3 |
Cost-effectiveness of an in-development adult-formulated 21-valent pneumococcal conjugate vaccine in US adults aged 50 years or older
|
Altawalbeh, Shoroq M.
|
|
|
42 |
12 |
p. 3024-3032
|
artikel
|
| 4 |
COVID-19 vaccine uptake among non-US-born populations in the United States, 2020–2022
|
Nolan, Margaret B.
|
|
|
42 |
12 |
p. 3115-3121
|
artikel
|
| 5 |
Dendritic cell targeting peptide plus Salmonella FliCd flagellin fused outer membrane protein H (OmpH) demonstrated increased efficacy against infections caused by different Pasteurella multocida serogroups in mouse models
|
Wang, Zihao
|
|
|
42 |
12 |
p. 3075-3083
|
artikel
|
| 6 |
Despite mandated primary series, health care personnel still hesitant about COVID-19 vaccine and immunizing children
|
Kainth, Mundeep K.
|
|
|
42 |
12 |
p. 3122-3133
|
artikel
|
| 7 |
Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial
|
Baum, Holly E.
|
|
|
42 |
12 |
p. 2945-2950
|
artikel
|
| 8 |
Early use of oral cholera vaccines as a prime control measure during outbreaks: Necessary but not sufficient
|
El Bushra, Hassan E.
|
|
|
42 |
12 |
p. 3033-3038
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
42 |
12 |
p. ii
|
artikel
|
| 10 |
Effectiveness of COVID-19 vaccination against school absenteeism in children and adolescents hospitalized with COVID-19
|
Maltezou, Helena C.
|
|
|
42 |
12 |
p. 2941-2944
|
artikel
|
| 11 |
Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistance
|
Grant, Lindsay R.
|
|
|
42 |
12 |
p. 2983-2993
|
artikel
|
| 12 |
Heritability and genome-wide association study of vaccine-induced immune response in Beagles: A pilot study
|
Blake, Jeanna M.
|
|
|
42 |
12 |
p. 3099-3106
|
artikel
|
| 13 |
Immunogenicity and safety of adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants ≥ 2 and < 43 months of Age: A phase III, multicenter, active controlled, assessor-blinded, randomized, parallel-group study
|
Nakano, Takashi
|
|
|
42 |
12 |
p. 3134-3143
|
artikel
|
| 14 |
Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trial
|
Nurdin, Asrawati
|
|
|
42 |
12 |
p. 3009-3017
|
artikel
|
| 15 |
Immunogenicity and safety of Sinovac-CoronaVac booster vaccinations in 12–17- year-olds with clinically significant reactions from Pfizer-BNT162b2 vaccination
|
Chong, Chia-Yin
|
|
|
42 |
12 |
p. 2951-2954
|
artikel
|
| 16 |
Indirect vaccine effectiveness in an outbreak of Alpha B.1.1.7 variant in a California state Prison, May 2021
|
Archer, Helena
|
|
|
42 |
12 |
p. 3057-3065
|
artikel
|
| 17 |
Is vaccination against measles, mumps, and rubella associated with reduced rates of antibiotic treatments among children below the age of 2 years? Nationwide register-based study from Denmark, Finland, Norway, and Sweden
|
Gehrt, Lise
|
|
|
42 |
12 |
p. 2955-2965
|
artikel
|
| 18 |
Minimal interval for the administration of a pneumococcal polysaccharide vaccine following the administration of a pneumococcal conjugate vaccine
|
De Wals, Philippe
|
|
|
42 |
12 |
p. 2933-2936
|
artikel
|
| 19 |
Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda
|
Kimbugwe, Geofrey
|
|
|
42 |
12 |
p. 3002-3008
|
artikel
|
| 20 |
Poor association between 13-valent pneumococcal conjugate vaccine-induced serum and mucosal antibody responses with experimental Streptococcus pneumoniae serotype 6B colonisation
|
Tembo, G.
|
|
|
42 |
12 |
p. 2975-2982
|
artikel
|
| 21 |
Protective effect of PCV13 against all-cause hospitalized pneumonia in children in Beijing, China: real-world evidence
|
Lv, Min
|
|
|
42 |
12 |
p. 3091-3098
|
artikel
|
| 22 |
Reliance on sources of immunization information and vaccine uptake among older adults in a rural state: The mediating role of trust
|
Huseth-Zosel, Andrea L.
|
|
|
42 |
12 |
p. 3107-3114
|
artikel
|
| 23 |
Retrospective study on the health and economic burden of hospitalized patients due to pneumonia and invasive pneumococcal infections in Belgium settings
|
Magali, Pirson
|
|
|
42 |
12 |
p. 3018-3023
|
artikel
|
| 24 |
Safety profile of recombinant adjuvanted anti-herpes zoster vaccine (RZV) in high-risk groups: Data from active surveillance program. Puglia (Italy), 2021–23
|
Stefanizzi, Pasquale
|
|
|
42 |
12 |
p. 2966-2974
|
artikel
|
| 25 |
Self-reported determinants of COVID-19 vaccine acceptance among persons with and without autoimmune disease
|
Gong, Jenny D.
|
|
|
42 |
12 |
p. 2994-3001
|
artikel
|
| 26 |
The early safety profile of simultaneous vaccination against influenza and Respiratory Syncytial Virus (RSV) in patients with high-risk heart failure
|
Biegus, Jan
|
|
|
42 |
12 |
p. 2937-2940
|
artikel
|
| 27 |
Uptake of pneumococcal vaccines in older Australian adults before and after universal public funding of PCV13
|
Binte Hossain, Fariha
|
|
|
42 |
12 |
p. 3084-3090
|
artikel
|
| 28 |
Vaccine coverage among children born to immigrant parents in Norway, 2000–2020
|
Nybru Gleditsch, Rebecca
|
|
|
42 |
12 |
p. 3049-3056
|
artikel
|
Tijdschrift beschrijving